Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Galzin ® (zinc acetate capsules) is now available for maintenance treatment of ...

A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has completed their research in the field of artificial intelligence (AI)-powered ...

Eton Pharmaceuticals (NASDAQ:ETON) has acquired the drug Galzin, also known as zinc acetate, for the treatment of Wilson disease, an ultra-rare metabolic condition. Galzin is approved by the FDA as a ...

Eton Pharmaceuticals has launched Galzin® (zinc acetate) capsules, the only FDA-approved zinc therapy for Wilson disease patients who have previously been treated with a chelating agent. To enhance ...

Oppenheimer has initiated Monopar Therapeutics at outperform citing the potential of a candidate for the genetic disorder Wilson disease it acquired from AstraZeneca (AZN). The firm set a $77 price ...

Monopar Therapeutics Inc. presented new data on its drug candidate ALXN1840 (tiomolybdate choline) for Wilson disease at the European Association for the Study of the Liver International Liver ...

On Monday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced preclinical findings highlighting the copper-binding potential of its lead compound, Telomir-1, as a promising treatment for Wilson's ...

Research seems to be gaining ground in Wilson disease, a rare inherited condition that causes copper levels to accumulate in the liver, brain and eyes. Most people are diagnosed as children or around ...

In another example of the effect of modifier genes, Schiefermeier et al [45] tried to delineate why some patients have later-onset neurologic as well as hepatic symptoms by examining the potential ...

Richard Rosencrantz, M.D.; Michael Schilsky, M.D. On physical exam, patients early on may have hepatomegaly, and over time may be seen to develop signs of chronic liver injury and cirrhosis with ...